In the field of wound care, one of the most critical aspects is haemostasis – the process of stopping bleeding. Effective haemostasis is crucial to prevent further tissue damage, reduce the risk of infection, and promote optimal healing. Axiostat, a bioactive haemostatic dressing, has revolutionized the way we approach wound care by providing a unique solution for haemostasis and painless removal.
Axiostat's Bioactive Technology
Axiostat works on a charge-based mechanism of mucoadhesion, which forms a mechanical barrier on the bleeding site. This innovative technology allows Axiostat to:
- Achieve rapid and effective haemostasis
- Provide a gentle and non-traumatic removal process
- Minimize tissue damage and promote optimal healing
The Science Behind Axiostat's Success
Axiostat's unique bioactive technology is based on the principle of mucoadhesion, which enables it to form a strong bond with the wound bed. This bond creates a mechanical barrier that:
- Prevents further bleeding
- Provides a protective layer for the wound
- Allows for gentle removal without disrupting the healing process
Benefits of Axiostat
Axiostat offers numerous benefits for patients and healthcare professionals alike, including:
- Rapid haemostasis: Achieve effective bleeding control in minutes, reducing the risk of further tissue damage.
- Painless removal: Minimize patient discomfort during dressing changes by providing a gentle and non-traumatic removal process.
- Optimal healing: Promote wound healing through reduced inflammation, minimized scar tissue formation, and improved tissue integrity.
Non-Woven Microfibre Wound Dressing: The Next Generation of Wound Care
In addition to Axiostat's bioactive technology, the company also offers a range of non-woven microfibre wound dressings designed to manage exudate, reduce pain, and promote scar improvement. These dressings are:
- Highly absorbent: Quickly remove excess fluid and debris from the wound bed.
- Antimicrobial: Prevent bacterial growth and reduce the risk of infection.
- Breathable: Allow for optimal airflow and moisture management.
Bioactive Microfiber Gelling Technology (BMG™)
Axiostat's BMG technology is a patented innovation that combines the benefits of bioactive haemostasis with the versatility of microfibre wound dressings. BMG allows for:
- Rapid gelling: Quickly forms a gel-like substance to fill and secure the wound.
- Adaptable: Can be molded to fit irregularly shaped wounds or conform to specific wound sites.Axiostat's bioactive haemostatic dressing has revolutionized the way we approach wound care by providing a unique solution for haemostasis and painless removal. The company's non-woven microfibre wound dressings, combined with their BMG technology, offer a comprehensive range of solutions for managing exudate, reducing pain, and promoting optimal healing.